INDIA – Odisha is gearing up to become a key player in vaccine production with the impending launch of its first-ever vaccine manufacturing plant. 

 The Sapigen Biologix vaccine plant, located at the Biotech Park in Andharua, is poised to kickstart commercial production by May 2024, marking a significant milestone for the state. 

Anticipated to be a game-changer in the realm of vaccine manufacturing, the facility boasts a staggering capacity to churn out 2.4 crore doses of various vaccines daily. 

 This ambitious endeavor is set to position the plant as the largest vaccine-producing facility in the country, according to statements from the Chief Minister’s Office (CMO). 

The scope of the plant’s operations extends beyond domestic borders, as it aims to produce over 15 different vaccines targeting a range of diseases, including cholera and malaria. 

 With an investment of Rs 1,500 crore (about US$180 million), the project not only promises to bolster the state’s healthcare infrastructure but also generate direct employment opportunities for 1,500 individuals, with a focus on local recruitment. 

One of the key highlights of the initiative is its potential to contribute to global vaccine supply chains. 

 The diverse range of vaccines manufactured at the Bhubaneswar-based plant is expected to cater to international markets, further solidifying Odisha’s position on the global pharmaceutical map. 

V K Pandian, the chairman of ‘5T’ technology-led transformative initiatives, recently inspected the plant’s sub-units and engaged with its management and workforce. 

 Encouraging swift action, he urged all relevant government agencies to extend their support to ensure the timely commissioning of the plant within the next three months. 

As the countdown to operationalization continues, the Sapigen Biologix vaccine plant stands as a testament to Odisha’s commitment to healthcare innovation and economic growth.  

With its ambitious production capacity and global aspirations, the plant is poised to make a significant impact on public health initiatives, both locally and on a global scale. 

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.